Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
Main Authors: | Frank L J Visseren, Steven H J Hageman, Stian Lydersen, Hanne Ellekjaer, Ingvild Saltvedt, Jannick A N Dorresteijn, Olav Spigset, Mari Nordbø Gynnild |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-04-01
|
Series: | Open Heart |
Online Access: | https://openheart.bmj.com/content/9/1/e001972.full |
Similar Items
-
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention
by: Gynnild MN, et al.
Published: (2021-09-01) -
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study
by: Stina Aam, et al.
Published: (2021-08-01) -
Post-stroke Cognitive Impairment—Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study
by: Stina Aam, et al.
Published: (2020-07-01) -
Environmental factors and risk of delirium in geriatric patients: an observational study
by: Sigurd Evensen, et al.
Published: (2018-11-01) -
Origins and Previous Applications of Causal-Benefit Models
by: Jannick A.N. Dorresteijn, MD, PhD, MSc, et al.
Published: (2024-09-01)